Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany.

Molecular imaging and biology·2015

Same author

Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany.

Molecular imaging and biology·2015

Same author

[Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting].

Deutsche medizinische Wochenschrift (1946)·2014

Same author

Nuclear medicine training and practice in Germany.

European journal of nuclear medicine and molecular imaging·2013

Same author

[Nuclear medicine in Europe: education].

Nuklearmedizin. Nuclear medicine·2012

Same author

PET surveillance of patients with Ewing sarcomas of the trunk: Must the lower legs be included?

Nuklearmedizin. Nuclear medicine·2010

Search research articles

Related Experiment Video

Updated: Jun 9, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

FDG-PET/CT in pediatric solid tumors.

C Franzius¹

¹MRI, Nuclear Medicine and PET/CT Center Bremen, Bremen, Germany.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of

|September 9, 2010

Summary

Positron emission tomography/computed tomography (PET/CT) enhances pediatric cancer diagnosis and monitoring. Integrated PET/CT offers superior staging accuracy and patient management compared to standalone imaging modalities.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Jun 9, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Area of Science:

Nuclear medicine
Pediatric oncology
Medical imaging

Background:

Positron emission tomography/computed tomography (PET/CT) is crucial for evaluating pediatric malignant diseases.
FDG PET/CT aids in staging, therapy monitoring, and relapse detection for sarcoma patients.
FDG PET has limitations in detecting pulmonary metastases from sarcoma compared to CT.

Purpose of the Study:

To evaluate the role of PET/CT in pediatric oncology.
To highlight the advantages of integrated PET/CT over standalone modalities.
To discuss specific PET tracers in neuroblastoma and other pediatric malignancies.

Main Methods:

Review of current literature on PET/CT in pediatric malignancies.
Comparison of FDG PET/CT with chest CT for pulmonary metastases in sarcoma.
Discussion of specific PET tracers like HED and F-DOPA for neuroblastoma.

Main Results:

PET/CT overcomes FDG PET's limitations in detecting pulmonary metastases.
Specific PET tracers show potential for neuroblastoma, though studies are limited.
PET/CT provides combined morphological and functional information.

Conclusions:

Integrated PET/CT is anticipated to improve staging accuracy and patient management in pediatric oncology.
Further research is needed on specific PET tracers in pediatric malignancies.
PET/CT offers significant advantages in non-invasive evaluation and monitoring of pediatric cancers.